CClinicalTrials.gg
CompletedNCT04810403Updated May 4, 2022

SOMEBODY, a Social Media-based Eating Disorder Prevention Program

An interventional study of SOMEBODY Eating Disorder Prevention Program in Eating Disorder Symptom, sponsored by Florida State University. Completed at 1 site in United States. Open to female participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-04.

Sponsored by Florida State University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Not applicable
Ages
18 Years to 25 Years
Sex
Female
01

Study summary

The purpose of this study is to develop and evaluate the feasibility, acceptability, and preliminary evidence of potential efficacy of a social-media based intervention to reduce risk factors for eating disorders in college women.

Read the detailed description

Previous research supports an association between specific aspects of social media use and increased eating pathology in correlational designs and that specific aspects of social media use cause increases in risk factors for eating disorders. The aim of the current project is to determine whether social media use can be altered to cause decreases in eating disorder risk factors. To accomplish this, college women will be recruited to participate in an open trial of a pilot program that adapts activities used within evidence-based eating disorder prevention programs to be used on social media platforms. The intervention is designed to target internalization of the thin ideal.

02

Conditions studied

  • Eating Disorder Symptom
03

In context

Feeding and Eating Disorders

740 studies on the registry are indexed under Feeding and Eating Disorders; 159 are open to participants now.

This study's enrollment of 8 is below the median of 75 across 540 interventional studies indexed under Feeding and Eating Disorders.

Browse Feeding and Eating Disorders studies →

Lead sponsor

Florida State University is the lead sponsor of 241 studies on the registry; 46 are open to participants now.

Of its 15 completed or terminated interventional studies of FDA-regulated products, 9 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • female
  • 18 to 25 years old
  • score in the top 50th percentile for time spent on social media each day

Exclusion criteria

Exclusion Criteria:

  • male
  • \<18 years or >25 years old
  • individuals who screen positive for a Diagnostic Statistical Manual-5 eating disorder on the Eating Disorder Diagnostic Scale
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
8 participants (actual)

Study arms

  • Experimental
    SOMEBODY Eating Disorder Prevention Program

    All participants will be recruited to participate in the SOcial MEdia (SOME) adaptation of activities from the BODY Project (SOMEBODY).

    Behavioral: SOMEBODY Eating Disorder Prevention Program

Interventions

  • BehavioralSOMEBODY Eating Disorder Prevention Program

    Participants will receive daily activities to complete on their most frequently used social media platform for 14 consecutive days. Daily activities have been adapted from the Body Project - an intervention that has been demonstrated to reduce internalization of the thin ideal and reduce risk for eating disorders. Examples of activities to be piloted include unfollowing social media accounts the participant perceives as reinforcing the thin-ideal and posting a selfie without makeup or editing. Based on feedback from participants, the intervention may be altered to improve acceptability, feasibility, and preliminary evidence of potential efficacy.

06

What researchers measure

Primary outcomes

  1. Acceptability of intervention

    Acceptability will be evaluated with 7-point Likert scale ratings, with a score ≥5 indicating that participants found the intervention acceptable

    Time frame: 2 weeks

  2. Feasibility of intervention

    Feasibility will be evaluated as the percentage of consented and enrolled participants who complete ≥10 of the 14 days of the intervention, with ≥80% indicating feasibility

    Time frame: 2 weeks

  3. Change in internalization of the thin ideal

    The Sociocultural Attitudes Towards Appearance Questionnaire - 4 Revised (SATAQ-4R) Internalization Subscales will be used to measure internationalization of the thin ideal before and after the intervention. An effect size of d=.50 for within subject change in score will establish preliminary evidence of potential efficacy

    Time frame: Pre-intervention assessment to post-intervention assessment (or approximately 14 days from baseline)

Secondary outcomes

  1. Change in body image concerns

    The Eating Disorders Examination Questionnaire Weight and Shape Concerns subscales adapted for the past 7 days will be used to measure change in body image before and after the intervention

    Time frame: Pre-intervention assessment to post-intervention assessment (or approximately 14 days from baseline)

  2. Change in dietary restraint

    The Eating Disorders Examination Questionnaire Dietary Restraint subscale adapted for the past 7 days will be used to measure change in dietary restraint before and after the intervention

    Time frame: Pre-intervention assessment to post-intervention assessment (or approximately 14 days from baseline)

  3. Change in bulimic symptoms

    The Eating Disorders Examination Questionnaire Self-Reported Bulimic Symptom Composite Score adapted for the past 7 days will be used to measure change in bulimic symptom frequency before and after the intervention

    Time frame: Pre-intervention assessment to post-intervention assessment (or approximately 14 days from baseline)

  4. Change in disordered eating

    The Eating Disorders Examination Questionnaire Global Score adapted for the past 7 days will be used to measure change in disordered eating before and after the intervention

    Time frame: Pre-intervention assessment to post-intervention assessment (or approximately 14 days from baseline)

  5. Change in social media use

    The Social Media Use Questionnaire items assessing frequency and type of engagement with social media will be used to measure change in social media use before and after the intervention

    Time frame: Pre-intervention assessment to post-intervention assessment (or approximately 14 days from baseline)

  6. Adherence to protocol - self-reported

    The Social Media Use Questionnaire items assessing adherence to daily social media activities will be used to measure self-reported adherence after the intervention

    Time frame: 2 weeks

  7. Adherence to protocol - observed

    With participant consent, a research assistant will follow the social media account the participant plans to use for the SOMEBODY intervention and will complete a checklist on a daily basis (yes/no) on whether or not the participant completed the daily assignment

    Time frame: Daily for the 14 days of the intervention

07

Study locations

1 site
  • Florida State University Psychology Department
    Tallahassee, Florida 32304, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 4, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04810403
Lead sponsor
Florida State University
Responsible party
Pamela Keel (Professor, Florida State University) — Principal investigator
First posted
Mar 23, 2021
Start date
Mar 29, 2021
Primary completion
Apr 22, 2022
Completion
Apr 22, 2022
Last update
May 4, 2022

Study contacts

Pamela K Keel, Ph.D.
principal investigator · Florida State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion